Related Experiment Videos
Immunization of children with attenuated measles-rubella bivalent vaccine
Insights
Simultaneous administration of measles and rubella vaccines in a single injection proved safe and effective. This bivalent vaccine achieved high seroconversion rates, comparable to separate injections for measles and rubella immunity.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Measles and rubella are significant childhood infectious diseases.
- Combined measles-rubella (MR) vaccines are crucial for public health.
- Evaluating the safety and efficacy of bivalent vaccines administered simultaneously is essential.
Purpose of the Study:
- To assess the safety and immunogenicity of a combined Schwarz-strain measles virus vaccine and Cendehill-strain rubella virus vaccine.
- To compare the effects of simultaneous bivalent administration versus monovalent vaccines and placebo.
- To investigate the impact of varying component concentrations in bivalent preparations.
Main Methods:
- A double-blind protocol involving 346 susceptible children.
- Four bivalent vaccine preparations with varying component concentrations were tested.
- Included placebo and monovalent vaccine controls for comparison.
Main Results:
- No unusual adverse reactions were observed with simultaneous bivalent administration.
- Seroconversion rates for measles were high (97-100%) in bivalent groups, similar to monovalent controls.
- Seroconversion rates for rubella were also high (94-100%) in bivalent groups, comparable to monovalent controls.
Conclusions:
- Simultaneous administration of Schwarz-strain measles and Cendehill-strain rubella vaccines is safe and does not enhance clinical reactivity.
- The bivalent vaccine elicits immune responses (seroconversion) comparable to individual monovalent vaccines.
- Combined measles and rubella vaccination is an effective strategy for achieving dual immunity.
Abstract:
The effects of simultaneous administration of Schwarz-strain measles virus vaccine and Cendehill-strain rubella virus vaccine as a single bivalent injection was evaluated in 346 children susceptible to both diseases. With placebo and monovalent controls, four bivalent preparations were used in a double-blind protocol to determine the effects of variations in the concentration of one or both components. No unusual reactions occurred and simultaneous administration did not enhance clinical reactivity. For measles, the seroconversion rate was 97% for monovalent vaccine and 97% to 100% (average 98%) for bivalent vaccines. For rubella, the rate was 100% for monovalent vaccine and 94% to 100% (average 99%) for bivalent vaccines. Thus, the vaccines were as safe and effective when given together as when given separately.